SlideShare a Scribd company logo
1 of 2
Carcinoma of unknown primary origin 
(CUP)-198 
Unknown or occult primary carcinoma is the presentation of metastatic neck lymphadenopathy 
without the development of a primary lesion within a subsequent five –year period. 
Failure to identify an occult primary has been attributed to either spontaneous regression of the 
primary tumour, autoimmune destruction, or possibly accelerated tumour progression. 
The term carcinoma of unknown primary origin should be used if no evidence of primary tumour is 
found after adequate clinical examination,fibreoptic endoscopy & conventional radiological 
investigations. It is about 2-3% of patients with head &neck malignancy.Metastases most commonly 
occur at levels II &III, squamous cells carcinoma is most common.Five years survival rate exceeding 
50% ,irrespective of the management. 
Isolated supraclavicular nodal involvement is almost invariably related to malignant disease arising 
below the clavicles. 
Diagnosis 
1)History 
2)Clinical examination with nasoendoscopic examination of upper GIT. 
3)FNAC & in case of uncertainity ,open biopsy is necessary. 
The majority of the patients presenting with levels II/III mass will have a primary tumour of 
submucosa of the tongue base or tonsil. 
The diagnosis of a brachial cyst in patients with over the age of 40years ,following excision to 
report the presence of metastatic squamous cells carcinoma. It may be cyctic metastases from a 
tongue base or tonsil carcinoma. 
4)Chest x-ray to exclude primary Bronchial carcinoma. 
5) CT/MRI or PET-CT fusion imaging.PET using 18-fluorodeoxyglucose is a promising disease 
detection modalities because of its ability to differentiate between tissue with a high rate of 
metabolism such as tumour ,inflammation or infection & tissue with a low metabolic rate like scar. 
PET-CT offer greater sensitivity,selectivity, & specificity & also reduced number of false –positive 
results. PET-CT prior to endoscopy & biopsy. Once the biopsy have been carried out ,PET scan need 
to be delayed 6wks to prevent false result. 
6) Panendoscopy with Biopsy; laryngo –pharyngo-oesophagoscopy under G/A;in the absence of an 
obvious primary on endoscopy, tonsillectomy ,Tongue base biopsy,Biopsy of the postnasal space & 
pyriform fossa.
25% cancer found ipsilateral to the nodal metastases,10% contralateral, so bilateral tonsillectomy 
preferred. 
Submucosal tongue base biopsy ; wedge biopsy ,cutting deeply into the tongue base rather than just 
using cupped forceps. 
All these clinical examination, CT/MRI, Panendoscopy with biopsy can reveal the primary site over 
40%. Diagnostic accuracy may be further enhanced by using laser –induced fluorescence endoscopy. 
(enhanced by 15-38%). 
Treatment of CUP 
Modified neck dissection is recommened for all patients with CUP with cervical lymphadenopathy. 
Post-operative selective or panmucosal radiotherapy is indicated for most patients with advanced 
operable neck disease.Amifostine a radioprotecting agent to protect salivary glands. 
Intensity modulated radiotherapy(IMRT) a technique for delivering tumoricidal radiation doses to 
mucasal sites. (a reduction dose to sensitive major salivary glands). 
Shehadeh reported a benefit in locoregional control with postoperative radiotherapy with 
concurrent cisplatin (100mg per m2 given 3 wkly).

More Related Content

What's hot

Immunohistochemical diagnosis of carcinoma from an unkown primary
Immunohistochemical diagnosis of carcinoma from an unkown primaryImmunohistochemical diagnosis of carcinoma from an unkown primary
Immunohistochemical diagnosis of carcinoma from an unkown primary
krish penugonda
 
CANCER of UNKNOWN PRIMARY (CUP), Dr BÙI ĐẮC CHÍ
CANCER of UNKNOWN PRIMARY (CUP), Dr BÙI ĐẮC CHÍCANCER of UNKNOWN PRIMARY (CUP), Dr BÙI ĐẮC CHÍ
CANCER of UNKNOWN PRIMARY (CUP), Dr BÙI ĐẮC CHÍ
hungnguyenthien
 
Rare Solid Cancers: An Introduction - Slide 10 - V. Kataja - Rare urological ...
Rare Solid Cancers: An Introduction - Slide 10 - V. Kataja - Rare urological ...Rare Solid Cancers: An Introduction - Slide 10 - V. Kataja - Rare urological ...
Rare Solid Cancers: An Introduction - Slide 10 - V. Kataja - Rare urological ...
European School of Oncology
 
Carcinoid tumours of small intestine; surgical aspect
Carcinoid tumours of small intestine; surgical aspectCarcinoid tumours of small intestine; surgical aspect
Carcinoid tumours of small intestine; surgical aspect
Daifallah Almansouri
 

What's hot (20)

Immunohistochemical diagnosis of carcinoma from an unkown primary
Immunohistochemical diagnosis of carcinoma from an unkown primaryImmunohistochemical diagnosis of carcinoma from an unkown primary
Immunohistochemical diagnosis of carcinoma from an unkown primary
 
CANCER of UNKNOWN PRIMARY (CUP), Dr BÙI ĐẮC CHÍ
CANCER of UNKNOWN PRIMARY (CUP), Dr BÙI ĐẮC CHÍCANCER of UNKNOWN PRIMARY (CUP), Dr BÙI ĐẮC CHÍ
CANCER of UNKNOWN PRIMARY (CUP), Dr BÙI ĐẮC CHÍ
 
Use of algorithm in IHC
Use of algorithm in IHCUse of algorithm in IHC
Use of algorithm in IHC
 
Staging an tumor markers
Staging an tumor markersStaging an tumor markers
Staging an tumor markers
 
Urothelial ca urinary markers
Urothelial ca urinary markersUrothelial ca urinary markers
Urothelial ca urinary markers
 
Metastasis of unknown origin ppt final ppt
Metastasis of unknown origin ppt final pptMetastasis of unknown origin ppt final ppt
Metastasis of unknown origin ppt final ppt
 
Rare Solid Cancers: An Introduction - Slide 10 - V. Kataja - Rare urological ...
Rare Solid Cancers: An Introduction - Slide 10 - V. Kataja - Rare urological ...Rare Solid Cancers: An Introduction - Slide 10 - V. Kataja - Rare urological ...
Rare Solid Cancers: An Introduction - Slide 10 - V. Kataja - Rare urological ...
 
TUMOR MARKERS OF COLORECTAL CARCINOMA
TUMOR MARKERS OF  COLORECTAL CARCINOMATUMOR MARKERS OF  COLORECTAL CARCINOMA
TUMOR MARKERS OF COLORECTAL CARCINOMA
 
Tumour markers - for surgeons
Tumour markers - for surgeonsTumour markers - for surgeons
Tumour markers - for surgeons
 
2015 fellows lecture version d
2015 fellows lecture version d2015 fellows lecture version d
2015 fellows lecture version d
 
20 4-13grading & staging tumour markers
20 4-13grading & staging tumour markers20 4-13grading & staging tumour markers
20 4-13grading & staging tumour markers
 
Recent advances in pancreatic pathology
Recent advances in pancreatic pathology Recent advances in pancreatic pathology
Recent advances in pancreatic pathology
 
Recent advances in colorectal carcinoma
Recent advances in colorectal carcinomaRecent advances in colorectal carcinoma
Recent advances in colorectal carcinoma
 
Neck node with unknown primary dipalee
Neck node with unknown primary  dipaleeNeck node with unknown primary  dipalee
Neck node with unknown primary dipalee
 
10 testicular cancer
10 testicular cancer10 testicular cancer
10 testicular cancer
 
Recent advances on colo rectal carcinoma1
Recent advances on colo rectal carcinoma1Recent advances on colo rectal carcinoma1
Recent advances on colo rectal carcinoma1
 
Rcc and bladder cancer
Rcc and bladder cancerRcc and bladder cancer
Rcc and bladder cancer
 
Carcinoid tumours of small intestine; surgical aspect
Carcinoid tumours of small intestine; surgical aspectCarcinoid tumours of small intestine; surgical aspect
Carcinoid tumours of small intestine; surgical aspect
 
Lynch Syndrome and Serrated Polyposis Syndrome in 20 minutes.
Lynch Syndrome and Serrated Polyposis Syndrome in 20 minutes.Lynch Syndrome and Serrated Polyposis Syndrome in 20 minutes.
Lynch Syndrome and Serrated Polyposis Syndrome in 20 minutes.
 
Serrated pathway to colorectal neoplasia
Serrated pathway to colorectal neoplasiaSerrated pathway to colorectal neoplasia
Serrated pathway to colorectal neoplasia
 

Similar to Carcinoma of unknown primary origin (cup) 198

Carcinoma Colon And Management
Carcinoma Colon And ManagementCarcinoma Colon And Management
Carcinoma Colon And Management
PGIMER, AIIMS
 
Management of anal canal tumors with emphasis on treatment(1)
Management of  anal canal tumors with emphasis on treatment(1)Management of  anal canal tumors with emphasis on treatment(1)
Management of anal canal tumors with emphasis on treatment(1)
SabaMajid5
 
Staging and investigation of cervix and uterus
Staging and investigation of cervix and uterusStaging and investigation of cervix and uterus
Staging and investigation of cervix and uterus
AtulGupta369
 
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...
European School of Oncology
 

Similar to Carcinoma of unknown primary origin (cup) 198 (20)

NECK METASTASIS FROM AN UNKNOWN PRIMARY - RECENT ADVANCES
NECK METASTASIS FROM AN UNKNOWN PRIMARY - RECENT ADVANCESNECK METASTASIS FROM AN UNKNOWN PRIMARY - RECENT ADVANCES
NECK METASTASIS FROM AN UNKNOWN PRIMARY - RECENT ADVANCES
 
Metastasis of Neck Node with Unknown Primary
Metastasis of Neck Node with Unknown Primary Metastasis of Neck Node with Unknown Primary
Metastasis of Neck Node with Unknown Primary
 
Carcinoma Colon And Management
Carcinoma Colon And ManagementCarcinoma Colon And Management
Carcinoma Colon And Management
 
Ca lung (Workup and Diagnosis)
Ca lung (Workup and Diagnosis)Ca lung (Workup and Diagnosis)
Ca lung (Workup and Diagnosis)
 
Management of anal canal tumors with emphasis on treatment(1)
Management of  anal canal tumors with emphasis on treatment(1)Management of  anal canal tumors with emphasis on treatment(1)
Management of anal canal tumors with emphasis on treatment(1)
 
Git 4th 4th.
Git 4th 4th.Git 4th 4th.
Git 4th 4th.
 
Testicular tumor
Testicular tumorTesticular tumor
Testicular tumor
 
Git Esophageal Cancer.
Git Esophageal Cancer.Git Esophageal Cancer.
Git Esophageal Cancer.
 
Testicular tumors-Cassification, Biomarkers and Staging by Dr Rajesh
Testicular tumors-Cassification, Biomarkers and Staging by Dr RajeshTesticular tumors-Cassification, Biomarkers and Staging by Dr Rajesh
Testicular tumors-Cassification, Biomarkers and Staging by Dr Rajesh
 
LUNG CANCER MANAGEMENT IN LOW RESOURCE SETTINGS
LUNG CANCER MANAGEMENT IN LOW RESOURCE SETTINGSLUNG CANCER MANAGEMENT IN LOW RESOURCE SETTINGS
LUNG CANCER MANAGEMENT IN LOW RESOURCE SETTINGS
 
document.pptx
document.pptxdocument.pptx
document.pptx
 
Carcinoma Endometrium DR H.K.Cheema Professor-OBG,PIMS Jalandhar
Carcinoma Endometrium   DR H.K.Cheema Professor-OBG,PIMS JalandharCarcinoma Endometrium   DR H.K.Cheema Professor-OBG,PIMS Jalandhar
Carcinoma Endometrium DR H.K.Cheema Professor-OBG,PIMS Jalandhar
 
Staging and investigation of cervix and uterus
Staging and investigation of cervix and uterusStaging and investigation of cervix and uterus
Staging and investigation of cervix and uterus
 
cups neck by Dr. Musaib Mushtaq.ppt
cups neck by Dr. Musaib Mushtaq.pptcups neck by Dr. Musaib Mushtaq.ppt
cups neck by Dr. Musaib Mushtaq.ppt
 
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...
 
Unusual Nonepithelial cancers of H&N
Unusual Nonepithelial cancers of H&NUnusual Nonepithelial cancers of H&N
Unusual Nonepithelial cancers of H&N
 
Peritoneal surface malignancy
Peritoneal surface malignancyPeritoneal surface malignancy
Peritoneal surface malignancy
 
Anal canal cancer
Anal canal cancerAnal canal cancer
Anal canal cancer
 
Nasopharyngeal carcinoma
Nasopharyngeal carcinomaNasopharyngeal carcinoma
Nasopharyngeal carcinoma
 
8. Breast Cancer Diagnostic Workup .pptx
8. Breast Cancer Diagnostic Workup .pptx8. Breast Cancer Diagnostic Workup .pptx
8. Breast Cancer Diagnostic Workup .pptx
 

More from Shekhar Krishna Debnath

Tumours of the head & neck in the childhood
Tumours of the head & neck in the childhoodTumours of the head & neck in the childhood
Tumours of the head & neck in the childhood
Shekhar Krishna Debnath
 
Fungi( all fungal sinusitis & candidiasis)
Fungi( all fungal sinusitis & candidiasis)Fungi( all fungal sinusitis & candidiasis)
Fungi( all fungal sinusitis & candidiasis)
Shekhar Krishna Debnath
 
Branchial arch fistulae, thyroglossal duct anomalies& lymphangioma
Branchial arch fistulae, thyroglossal duct anomalies& lymphangiomaBranchial arch fistulae, thyroglossal duct anomalies& lymphangioma
Branchial arch fistulae, thyroglossal duct anomalies& lymphangioma
Shekhar Krishna Debnath
 

More from Shekhar Krishna Debnath (20)

Pta(sbo 3)
Pta(sbo 3)Pta(sbo 3)
Pta(sbo 3)
 
Vertigo
VertigoVertigo
Vertigo
 
Stridor vol 1
Stridor vol  1Stridor vol  1
Stridor vol 1
 
Obstuctive sleep apnoea in children
Obstuctive sleep apnoea in childrenObstuctive sleep apnoea in children
Obstuctive sleep apnoea in children
 
Nose
NoseNose
Nose
 
Diseases of the tonsils 2
Diseases of  the tonsils 2Diseases of  the tonsils 2
Diseases of the tonsils 2
 
Disease of tonsils
Disease of tonsilsDisease of tonsils
Disease of tonsils
 
Corticosteroid in otolaryngology
Corticosteroid in otolaryngologyCorticosteroid in otolaryngology
Corticosteroid in otolaryngology
 
Viruses & antiviral agents
Viruses & antiviral agentsViruses & antiviral agents
Viruses & antiviral agents
 
Tumours of the head & neck in the childhood
Tumours of the head & neck in the childhoodTumours of the head & neck in the childhood
Tumours of the head & neck in the childhood
 
The adenoid & adenoidectomy
The adenoid & adenoidectomyThe adenoid & adenoidectomy
The adenoid & adenoidectomy
 
Otitis media with effusion
Otitis media with effusionOtitis media with effusion
Otitis media with effusion
 
Gastro oesophageal reflux & aspiration
Gastro oesophageal reflux & aspirationGastro oesophageal reflux & aspiration
Gastro oesophageal reflux & aspiration
 
Fungi( all fungal sinusitis & candidiasis)
Fungi( all fungal sinusitis & candidiasis)Fungi( all fungal sinusitis & candidiasis)
Fungi( all fungal sinusitis & candidiasis)
 
Diseases of the tonsil
Diseases of the tonsilDiseases of the tonsil
Diseases of the tonsil
 
Chronic otitis media in childhood
Chronic otitis media in childhoodChronic otitis media in childhood
Chronic otitis media in childhood
 
Branchial arch fistulae, thyroglossal duct anomalies& lymphangioma
Branchial arch fistulae, thyroglossal duct anomalies& lymphangiomaBranchial arch fistulae, thyroglossal duct anomalies& lymphangioma
Branchial arch fistulae, thyroglossal duct anomalies& lymphangioma
 
Antimicrobial therapy
Antimicrobial therapyAntimicrobial therapy
Antimicrobial therapy
 
Acute otitis media in children
Acute otitis media in childrenAcute otitis media in children
Acute otitis media in children
 
Physiology of swallowing
Physiology of swallowingPhysiology of swallowing
Physiology of swallowing
 

Carcinoma of unknown primary origin (cup) 198

  • 1. Carcinoma of unknown primary origin (CUP)-198 Unknown or occult primary carcinoma is the presentation of metastatic neck lymphadenopathy without the development of a primary lesion within a subsequent five –year period. Failure to identify an occult primary has been attributed to either spontaneous regression of the primary tumour, autoimmune destruction, or possibly accelerated tumour progression. The term carcinoma of unknown primary origin should be used if no evidence of primary tumour is found after adequate clinical examination,fibreoptic endoscopy & conventional radiological investigations. It is about 2-3% of patients with head &neck malignancy.Metastases most commonly occur at levels II &III, squamous cells carcinoma is most common.Five years survival rate exceeding 50% ,irrespective of the management. Isolated supraclavicular nodal involvement is almost invariably related to malignant disease arising below the clavicles. Diagnosis 1)History 2)Clinical examination with nasoendoscopic examination of upper GIT. 3)FNAC & in case of uncertainity ,open biopsy is necessary. The majority of the patients presenting with levels II/III mass will have a primary tumour of submucosa of the tongue base or tonsil. The diagnosis of a brachial cyst in patients with over the age of 40years ,following excision to report the presence of metastatic squamous cells carcinoma. It may be cyctic metastases from a tongue base or tonsil carcinoma. 4)Chest x-ray to exclude primary Bronchial carcinoma. 5) CT/MRI or PET-CT fusion imaging.PET using 18-fluorodeoxyglucose is a promising disease detection modalities because of its ability to differentiate between tissue with a high rate of metabolism such as tumour ,inflammation or infection & tissue with a low metabolic rate like scar. PET-CT offer greater sensitivity,selectivity, & specificity & also reduced number of false –positive results. PET-CT prior to endoscopy & biopsy. Once the biopsy have been carried out ,PET scan need to be delayed 6wks to prevent false result. 6) Panendoscopy with Biopsy; laryngo –pharyngo-oesophagoscopy under G/A;in the absence of an obvious primary on endoscopy, tonsillectomy ,Tongue base biopsy,Biopsy of the postnasal space & pyriform fossa.
  • 2. 25% cancer found ipsilateral to the nodal metastases,10% contralateral, so bilateral tonsillectomy preferred. Submucosal tongue base biopsy ; wedge biopsy ,cutting deeply into the tongue base rather than just using cupped forceps. All these clinical examination, CT/MRI, Panendoscopy with biopsy can reveal the primary site over 40%. Diagnostic accuracy may be further enhanced by using laser –induced fluorescence endoscopy. (enhanced by 15-38%). Treatment of CUP Modified neck dissection is recommened for all patients with CUP with cervical lymphadenopathy. Post-operative selective or panmucosal radiotherapy is indicated for most patients with advanced operable neck disease.Amifostine a radioprotecting agent to protect salivary glands. Intensity modulated radiotherapy(IMRT) a technique for delivering tumoricidal radiation doses to mucasal sites. (a reduction dose to sensitive major salivary glands). Shehadeh reported a benefit in locoregional control with postoperative radiotherapy with concurrent cisplatin (100mg per m2 given 3 wkly).